Clinical Trial Update: Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on SENS 401 for severe or profound sudden sensorineural hearing loss has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• SENS-401

Snippet

Sponsor: Sensorion | Conditions: Severe Sudden Sensorineural Hearing Loss | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-03-01